Piper Jaffray Biotechnology Analyst Participates in Historical Medical Event at the Vatican Business Wire MINNEAPOLIS -- April 16, 2013 Piper Jaffray (NYSE: PJC) today announced that Edward Tenthoff, a senior research analyst covering the biotechnology sector, participated in a historical conference on adult stem cell research held at the Vatican last week. The International Vatican Adult Stem Cell Conference brought together a select group of scientists, physicians, religious leaders, industry representatives, politicians, the media and students to raise awareness of the therapeutic potential of adult stem cells. The event seeks to reduce misperceptions in cellular research and foster dialogue in order to identify unmet medical needs that can benefit from cell therapy. Tenthoff was one of just 350 in attendance and was responsible for moderating a cardiovascular medicine panel of leading physicians, researchers and industry representatives. "This event cemented our view that a revolution is quietly taking place in stem cell medicine. We say 'quietly' because the majority of the public nor investors realize just how close lifesaving therapies using stem cells actually are to the market," according to Tenthoff. "We see several investment opportunities for Piper Jaffray clients as new pivotal data, product approvals and partnerships emerge creating shareholder value." In addition, Piper Jaffray will be co-hosting RegenMed Investor Day, the first-ever investor event organized specifically for the regenerative medicine sector, on April 17 in New York. Speakers include Jeff Jonas, president of Shire Regenerative Medicine and Kieran Murphy, president and CEO of GE Healthcare Life Sciences. At this event, Tenthoff will be moderating a panel entitled "Regenerative Medicine in Wound Healing and Tissue Engineering." About Piper Jaffray Piper Jaffray is a leading investment bank and asset management firm serving clients in the U.S. and internationally. Our proven advisory teams combine deep industry, product and sector expertise with ready access to capital. Founded in 1895, the firm is headquartered in Minneapolis and has offices across the United States and in London and Zurich. www.piperjaffray.com Since 1895. MemberSIPCandNYSE. © 2013 Piper Jaffray Companies, 800 Nicollet Mall, Suite 800, Minneapolis, Minnesota 55402-7020 Contact: Piper Jaffray Companies Pamela Steensland, 612-303-8184 email@example.com
Piper Jaffray Biotechnology Analyst Participates in Historical Medical Event at the Vatican
Press spacebar to pause and continue. Press esc to stop.